ACME POCT

Acme POCT is a medical technology company specializing in the development and manufacturing of advanced point-of-care testing (POCT) diagnostic systems. Based in Hefei, China, the company focuses on microfluidic chemiluminescence immunoassay (mCLIA) technology, which integrates the high sensitivity of chemiluminescence with the efficiency of microfluidic chips. Their product portfolio features the A-2000 and A-3000 automated analyzers, designed for rapid and precise testing in emergency rooms, ICUs, and clinical laboratories. These platforms support a wide range of diagnostic assays, including markers for cardiac health, inflammation, infectious diseases, and hormones. Acme POCT aims to provide laboratory-grade diagnostic accuracy at the point of care to improve patient triage and clinical decision-making. The company is ISO 13485 certified and actively expands its commercial footprint across international markets.